Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials

Oncology (United States) · Published 2024-06-05 · DOI 10.46883/2024.25921023

Authors being retrieved — see the publisher record. https://doi.org/10.46883/2024.25921023

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Efficacy and Safety of Zolbetuximab in Gastric Cancer · Oncology (United States) · 2024 · Same journal
• A Multicenter Quality Audit Standardizing Esophageal Contouring in Postmastectomy Radiotherapy. · Oncology (United States) · 2026 · Same journal
• A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation · Oncology (United States) · 2024 · Same journal
• GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer · Oncology (United States) · 2025 · Same journal
• Improving Leukoplakia Follow-Up: Information Leaflets, Habit Cessation Counseling · Oncology (United States) · 2025 · Same journal
• Insights, Knowledge Gaps, and Priorities in Marginal Zone Lymphoma Research · Oncology (United States) · 2025 · Same journal
• A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck · Oncology (United States) · 2025 · Same journal
• Late Hepatic Recurrence From Granulosa Cell Tumor: A Case Report · Oncology (United States) · 2025 · Same journal
• Artificial Intelligence in Cancer Care: Addressing Challenges and Health Equity · Oncology (United States) · 2025 · Same journal
• Updates in Surgical Management of the Axilla · Oncology (United States) · 2025 · Same journal